Innovation1 Biotech Inc. Quarterly Debt-to-equity in % from Q2 2016 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Innovation1 Biotech Inc. quarterly Debt-to-equity history and growth rate from Q2 2016 to Q3 2023.
  • Innovation1 Biotech Inc. Debt-to-equity for the quarter ending August 31, 2023 was 768 %, a 509% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 768 +642 +509% Aug 31, 2023
Q2 2023 629 +532 +549% May 31, 2023
Q1 2023 185 Feb 28, 2023
Q4 2022 143 Nov 30, 2022
Q3 2022 126 Aug 31, 2022
Q2 2022 96.9 May 31, 2022
Q3 2017 -135 -23 -20.6% Aug 31, 2017
Q2 2017 -104 +7.05 +6.36% May 31, 2017
Q1 2017 -105 Feb 28, 2017
Q4 2016 -107 Nov 30, 2016
Q3 2016 -112 Aug 31, 2016
Q2 2016 -111 May 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.